SKI Market

Indian Indices

Sensex

76,863.71 -1,342.27
( -1.72%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

55,018.23 769.84
(1.42%)

Nikkei 225

10,315.38 -96.86
(-0.93%)

Forex

USD-INR

92.14 0.30
(0.32%)

EUR-INR

106.58 -0.02
(-0.02%)

GBP-INR

123.09 0.04
(0.04%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1142.874838

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

29.9

66174.44

EPS(TTM)

Face Value()

Div & Yield %

185.12

0.81

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	8831.13	9747.72	9054.55	8829.81	7219.68	6677.08
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	8831.13	9747.72	9054.55	8829.81	7219.68	6677.08
Other Income	698.23	305.99	266.29	199.89	190.01	95.98
Stock Adjustments	-56.61	71.31	-257.73	360.90	301.29	33.69
Total Income	9472.75	10125.02	9063.11	9390.60	7710.98	6806.75
EXPENDITURE :
Raw Materials	2785.53	3878.63	3572.91	3926.79	2966.31	2584.25
Power & Fuel Cost	128.35	123.85	126.32	129.53	100.12	106.08
Employee Cost	1723.09	1560.28	1516.22	1434.49	1158.72	1066.76
Other Manufacturing Expenses	509.57	439.03	361.12	399.80	280.51	276.78
Selling & Administrative Expenses	1339.94	1608.76	1739.71	1438.80	1007.42	1158.51
Miscellaneous Expenses	131.84	307.18	103.59	50.94	71.74	50.74
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	6618.32	7917.73	7419.87	7380.35	5584.82	5243.12
Operating Profit	2854.43	2207.29	1643.24	2010.25	2126.16	1563.63
Interest	76.11	81.91	86.40	37.90	42.93	38.71
Gross Profit	2778.32	2125.38	1556.84	1972.35	2083.23	1524.92
Depreciation	283.61	244.35	229.85	218.98	198.93	186.84
Profit Before Tax	2494.71	1881.03	1326.99	1753.37	1884.30	1338.08
Tax	261.10	333.28	227.52	303.82	331.83	246.95
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-47.28	-199.40	-35.00	-91.70	-132.61	-173.29
Reported Net Profit	2280.89	1747.15	1134.47	1541.25	1685.08	1264.42
Extraordinary Items	4.20	-54.86	-10.24	1.82	16.49	3.07
Adjusted Net Profit	2276.69	1802.01	1144.71	1539.43	1668.59	1261.35
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-73.21
P & L Balance brought forward	8640.88	7431.77	6823.39	5700.62	4350.32	3517.81
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	502.17	538.04	526.09	418.48	334.78	358.70
P & L Balance carried down	10419.60	8640.88	7431.77	6823.39	5700.62	4350.32
Dividend	0.00	0.00	0.00	0.00	0.00	263.05
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	2250.00	2000.00	2500.00	1700.00	1500.00	1250.00
Dividend Per Share(Rs)	45.00	40.00	50.00	34.00	30.00	25.00
Earnings Per Share-Unit Curr	190.79	146.14	94.90	128.92	140.95	105.76
Earnings Per Share(Adj)-Unit Curr	190.79	146.14	94.90	128.92	140.95	105.76
Book Value-Unit Curr	1030.68	882.86	782.09	731.38	637.87	525.34
Book Value(Adj)-Unit Curr	1030.68	882.86	782.09	731.38	637.87	525.34

76,863.71 -1,342.27 ( -1.72%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

55,018.23 769.84 (1.42%)

10,315.38 -96.86 (-0.93%)

92.14 0.30 (0.32%)

106.58 -0.02 (-0.02%)

123.09 0.04 (0.04%)

0.58 0.00 (0.05%)